These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 19808288)

  • 21. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
    Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed enhancement in hypertrophic cardiomyopathy: comparison with myocardial tagging MRI.
    Kim YJ; Choi BW; Hur J; Lee HJ; Seo JS; Kim TH; Choe KO; Ha JW
    J Magn Reson Imaging; 2008 May; 27(5):1054-60. PubMed ID: 18425835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular magnetic resonance signs of ischemia in hypertrophic cardiomyopathy.
    Melacini P; Corbetti F; Calore C; Pescatore V; Smaniotto G; Pavei A; Bobbo F; Cacciavillani L; Iliceto S
    Int J Cardiol; 2008 Aug; 128(3):364-73. PubMed ID: 17643520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association between delayed enhancement on cardiac magnetic resonance imaging and arrhythmia in patients with hypertrophic cardiomyopathy].
    WANG J; KONG XQ; XU HB; ZHOU GF; LIU F; SHI HJ; LIU DX
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):775-80. PubMed ID: 21092642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scoring of late gadolinium enhancement in cardiac magnetic resonance imaging can predict cardiac events in patients with hypertrophic cardiomyopathy.
    Nojiri A; Hongo K; Kawai M; Komukai K; Sakuma T; Taniguchi I; Yoshimura M
    J Cardiol; 2011 Nov; 58(3):253-60. PubMed ID: 21890327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy caused by mutations in troponin I.
    Moon JC; Mogensen J; Elliott PM; Smith GC; Elkington AG; Prasad SK; Pennell DJ; McKenna WJ
    Heart; 2005 Aug; 91(8):1036-40. PubMed ID: 16020591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.
    Wilson JM; Villareal RP; Hariharan R; Massumi A; Muthupillai R; Flamm SD
    Tex Heart Inst J; 2002; 29(3):176-80. PubMed ID: 12224720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy.
    Roldán V; Marín F; Gimeno JR; Ruiz-Espejo F; González J; Feliu E; García-Honrubia A; Saura D; de la Morena G; Valdés M; Vicente V
    Am Heart J; 2008 Jul; 156(1):85-91. PubMed ID: 18585501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event.
    Binkley PF; Lesinski A; Ferguson JP; Hatton PS; Yamokoski L; Hardikar S; Cooke GE; Leier CV
    Am Heart J; 2008 Jan; 155(1):69-74. PubMed ID: 18082492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late enhancement detected by cardiac magnetic resonance imaging in acute myocarditis mimicking acute myocardial infarction: location patterns and lack of correlation with systolic function.
    Camastra GS; Cacciotti L; Marconi F; Sbarbati S; Pironi B; Ansalone G
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1029-33. PubMed ID: 18163015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cumulative exercise-induced left ventricular systolic and diastolic dysfunction in hypertrophic cardiomyopathy.
    Pelliccia F; Cianfrocca C; Pristipino C; Pasceri V; Auriti A; Richichi G; Mangieri E; Gaudio C
    Int J Cardiol; 2007 Oct; 122(1):76-8. PubMed ID: 17196685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy.
    Saito M; Okayama H; Yoshii T; Higashi H; Morioka H; Hiasa G; Sumimoto T; Inaba S; Nishimura K; Inoue K; Ogimoto A; Shigematsu Y; Hamada M; Higaki J
    Eur Heart J Cardiovasc Imaging; 2012 Jul; 13(7):617-23. PubMed ID: 22271116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by delayed-enhanced magnetic resonance imaging.
    Sato Y; Matsumoto N; Kunimasa T; Matsuo S; Yoda S; Tani S; Kunimoto S; Saito S; Hirayama A
    Int J Cardiol; 2008 Dec; 131(1):e41-3. PubMed ID: 17920709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Importance of left atrial size in predicting adverse clinical events in hypertrophic cardiomyopathy].
    Kahveci G; Bayrak F; Mutlu B; Başaran Y
    Turk Kardiyol Dern Ars; 2008 Dec; 36(8):541-5. PubMed ID: 19223720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial fibrosis and regional function in hypertrophic cardiomyopathy: may the force be with you.
    Carasso S; Rakowski H
    J Am Soc Echocardiogr; 2008 Dec; 21(12):1306-8. PubMed ID: 19041573
    [No Abstract]   [Full Text] [Related]  

  • 36. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
    Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging.
    Petersen SE; Jerosch-Herold M; Hudsmith LE; Robson MD; Francis JM; Doll HA; Selvanayagam JB; Neubauer S; Watkins H
    Circulation; 2007 May; 115(18):2418-25. PubMed ID: 17452610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of myocardial fibrosis patterns in patients with systolic dysfunction: prognostic significance for the prediction of sudden cardiac arrest or appropriate implantable cardiac defibrillator therapy.
    Almehmadi F; Joncas SX; Nevis I; Zahrani M; Bokhari M; Stirrat J; Fine NM; Yee R; White JA
    Circ Cardiovasc Imaging; 2014 Jul; 7(4):593-600. PubMed ID: 24902587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection and quantification of myocardial fibrosis in hypertrophic cardiomyopathy by contrast-enhanced cardiovascular magnetic resonance].
    Pujadas S; Carreras F; Arrastio X; Leta R; Vila M; Subirana MT; Bayés-Genís A; Pons-Lladó G
    Rev Esp Cardiol; 2007 Jan; 60(1):10-4. PubMed ID: 17288950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Images in cardiovascular medicine. Progressive myocardial fibrosis in a patient with apical hypertrophic cardiomyopathy detected by cardiovascular magnetic resonance.
    Gebker R; Neuss M; Paetsch I; Nagel E
    Circulation; 2006 Aug; 114(5):e75-6. PubMed ID: 16880332
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.